These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 20551050)

  • 1. Extracellular protease ADAMTS9 suppresses esophageal and nasopharyngeal carcinoma tumor formation by inhibiting angiogenesis.
    Lo PH; Lung HL; Cheung AK; Apte SS; Chan KW; Kwong FM; Ko JM; Cheng Y; Law S; Srivastava G; Zabarovsky ER; Tsao SW; Tang JC; Stanbridge EJ; Lung ML
    Cancer Res; 2010 Jul; 70(13):5567-76. PubMed ID: 20551050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADAMTS9 is a cell-autonomously acting, anti-angiogenic metalloprotease expressed by microvascular endothelial cells.
    Koo BH; Coe DM; Dixon LJ; Somerville RP; Nelson CM; Wang LW; Young ME; Lindner DJ; Apte SS
    Am J Pathol; 2010 Mar; 176(3):1494-504. PubMed ID: 20093484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a novel epigenetically-silenced, growth-suppressive gene, ADAMTS9, and its association with lymph node metastases in nasopharyngeal carcinoma.
    Lung HL; Lo PHY; Xie D; Apte SS; Cheung AKL; Cheng Y; Law EWL; Chua D; Zeng YX; Tsao SW; Stanbridge EJ; Lung ML
    Int J Cancer; 2008 Jul; 123(2):401-408. PubMed ID: 18449890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-angiogenic pathway associations of the 3p21.3 mapped BLU gene in nasopharyngeal carcinoma.
    Cheng Y; Ho RL; Chan KC; Kan R; Tung E; Lung HL; Yau WL; Cheung AK; Ko JM; Zhang ZF; Luo DZ; Feng ZB; Chen S; Guan XY; Kwong D; Stanbridge EJ; Lung ML
    Oncogene; 2015 Aug; 34(32):4219-28. PubMed ID: 25347745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADAMTS9 is a functional tumor suppressor through inhibiting AKT/mTOR pathway and associated with poor survival in gastric cancer.
    Du W; Wang S; Zhou Q; Li X; Chu J; Chang Z; Tao Q; Ng EK; Fang J; Sung JJ; Yu J
    Oncogene; 2013 Jul; 32(28):3319-28. PubMed ID: 22907434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a tumor suppressive critical region mapping to 3p14.2 in esophageal squamous cell carcinoma and studies of a candidate tumor suppressor gene, ADAMTS9.
    Lo PH; Leung AC; Kwok CY; Cheung WS; Ko JM; Yang LC; Law S; Wang LD; Li J; Stanbridge EJ; Srivastava G; Tang JC; Tsao SW; Lung ML
    Oncogene; 2007 Jan; 26(1):148-57. PubMed ID: 16799631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetically upregulated oncoprotein PLCE1 drives esophageal carcinoma angiogenesis and proliferation via activating the PI-PLCε-NF-κB signaling pathway and VEGF-C/ Bcl-2 expression.
    Chen Y; Wang D; Peng H; Chen X; Han X; Yu J; Wang W; Liang L; Liu Z; Zheng Y; Hu J; Yang L; Li J; Zhou H; Cui X; Li F
    Mol Cancer; 2019 Jan; 18(1):1. PubMed ID: 30609930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 3p14.2 tumour suppressor ADAMTS9 is inactivated by promoter CpG methylation and inhibits tumour cell growth in breast cancer.
    Shao B; Feng Y; Zhang H; Yu F; Li Q; Tan C; Xu H; Ying J; Li L; Yang D; Peng W; Tang J; Li S; Ren G; Tao Q; Xiang T
    J Cell Mol Med; 2018 Feb; 22(2):1257-1271. PubMed ID: 29193730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.
    Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY
    Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protocadherin 8 (PCDH8) Inhibits Proliferation, Migration, Invasion, and Angiogenesis in Esophageal Squamous Cell Carcinoma.
    Yu H; Jiang X; Jiang L; Zhou H; Bao J; Zhu X; Liu F; Huang J
    Med Sci Monit; 2020 Apr; 26():e920665. PubMed ID: 32330123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catalytic activity of Matrix metalloproteinase-19 is essential for tumor suppressor and anti-angiogenic activities in nasopharyngeal carcinoma.
    Chan KC; Ko JM; Lung HL; Sedlacek R; Zhang ZF; Luo DZ; Feng ZB; Chen S; Chen H; Chan KW; Tsao SW; Chua DT; Zabarovsky ER; Stanbridge EJ; Lung ML
    Int J Cancer; 2011 Oct; 129(8):1826-37. PubMed ID: 21165953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastasis-suppressing NID2, an epigenetically-silenced gene, in the pathogenesis of nasopharyngeal carcinoma and esophageal squamous cell carcinoma.
    Chai AW; Cheung AK; Dai W; Ko JM; Ip JC; Chan KW; Kwong DL; Ng WT; Lee AW; Ngan RK; Yau CC; Tung SY; Lee VH; Lam AK; Pillai S; Law S; Lung ML
    Oncotarget; 2016 Nov; 7(48):78859-78871. PubMed ID: 27793011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor suppressor dual-specificity phosphatase 6 (DUSP6) impairs cell invasion and epithelial-mesenchymal transition (EMT)-associated phenotype.
    Wong VC; Chen H; Ko JM; Chan KW; Chan YP; Law S; Chua D; Kwong DL; Lung HL; Srivastava G; Tang JC; Tsao SW; Zabarovsky ER; Stanbridge EJ; Lung ML
    Int J Cancer; 2012 Jan; 130(1):83-95. PubMed ID: 21387288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCA1-Associated Protein Increases Invasiveness of Esophageal Squamous Cell Carcinoma.
    Zhao Y; Wei L; Shao M; Huang X; Chang J; Zheng J; Chu J; Cui Q; Peng L; Luo Y; Tan W; Tan W; Lin D; Wu C
    Gastroenterology; 2017 Nov; 153(5):1304-1319.e5. PubMed ID: 28780075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA Hotair mediated angiogenesis in nasopharyngeal carcinoma by direct and indirect signaling pathways.
    Fu WM; Lu YF; Hu BG; Liang WC; Zhu X; Yang HD; Li G; Zhang JF
    Oncotarget; 2016 Jan; 7(4):4712-23. PubMed ID: 26717040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADAMTS9 is Silenced by Epigenetic Disruption in Colorectal Cancer and Inhibits Cell Growth and Metastasis by Regulating Akt/p53 Signaling.
    Chen L; Tang J; Feng Y; Li S; Xiang Q; He X; Ren G; Peng W; Xiang T
    Cell Physiol Biochem; 2017; 44(4):1370-1380. PubMed ID: 29186710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of pigment epithelium-derived factor with radiotherapy enhances the antitumor effects on nasopharyngeal carcinoma by downregulating vascular endothelial growth factor expression and angiogenesis.
    Xu Z; Fang S; Zuo Y; Zhang Y; Cheng R; Wang Q; Yang Z; Cai W; Ma J; Yang X; Gao G
    Cancer Sci; 2011 Oct; 102(10):1789-98. PubMed ID: 21707863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-angiogenic and tumor-suppressive roles of candidate tumor-suppressor gene, Fibulin-2, in nasopharyngeal carcinoma.
    Law EW; Cheung AK; Kashuba VI; Pavlova TV; Zabarovsky ER; Lung HL; Cheng Y; Chua D; Lai-Wan Kwong D; Tsao SW; Sasaki T; Stanbridge EJ; Lung ML
    Oncogene; 2012 Feb; 31(6):728-38. PubMed ID: 21743496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGF.
    Li B; Xu WW; Han L; Chan KT; Tsao SW; Lee NPY; Law S; Xu LY; Li EM; Chan KW; Qin YR; Guan XY; He QY; Cheung ALM
    Oncogene; 2017 Jul; 36(28):3986-4000. PubMed ID: 28288140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evodiamine exerts anti-tumor effects against hepatocellular carcinoma through inhibiting β-catenin-mediated angiogenesis.
    Shi L; Yang F; Luo F; Liu Y; Zhang F; Zou M; Liu Q
    Tumour Biol; 2016 Sep; 37(9):12791-12803. PubMed ID: 27449032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.